Review: Updates in the Malaysian Patents Act 1983
The Intellectual Property Corporation of Malaysia (MyIPO) has recently announced that the Malaysian Patents Act 1983 will be amended to bring the Act into substantive conformity with international practices. Our attorneys attended a brief discussion with MyIPO and representatives from various local organizations in relation to the amendments, which will be presented at the House […]
[The Edge Malaysia] Malaysia as an Innovative Nation
KASS Managing Director, P. Kandiah, shares his thoughts on whether Malaysia is ready to become an Innovative Nation and what must be done so that our journey towards becoming a knowledge-based economy is not a wasted one: Malaysia as an Innovative Nation
[The Edge Malaysia] Malaysia as an Innovative Nation
KASS Managing Director, P. Kandiah, shares his thoughts on whether Malaysia is ready to become an Innovative Nation and what must be done so that our journey towards becoming a knowledge-based economy is not a wasted one: Malaysia as an Innovative Nation
Biosafety Act 2007
Malaysia has enacted Biosafety Act 2007 to regulate the release, import, export and contained use of ‘living modified organisms (LMOs)’ and the release of products of such organisms. The act has not come into force yet, as the enabling Regulations were not ready. Now the Biosafety Regulations 2009 draft is ready and is being discussed with […]
IP Clinic for Bionexus Companies
Malaysian Biotechnology Corporation Sdn. Bhd. organised its first ever IP Clinic for BioNexus Companies on 18th November 2008. KASS was privileged to conduct a Workshop on Patent Searches and lead a discussion on patent cases on pharmaceutical products in the morning. In the afternoon, KASS had IP Clinics on a one to one confidential basis with […]
Malaysia’s Biosafety Act Of 2007
With the growing influence of the biotechnology industry worldwide, Malaysia has enacted legislation to regulate the release, importation, exportation and contained use of living modified organisms and the release of products of such organisms. The objectives being to protect human, plant and animal health, the environment and biological diversity. The Act further provides that where […]
Completeness of Research For Obtaining a Patent
Biotechnology and Pharmaceutical product perspective. In many cases we often find that although researchers consider their research as complete, we take the view that the research is incomplete to justify the patent claims filed. This article proposes to discuss the requirements of one aspect of patentability. One of the three legal requirements to obtain a […]
KASS Conducts IPR Training Workshop
A leading biotechnology company recently engaged KASS International Sdn Bhd to design, develop and conduct an advanced training workshop on Intellectual Property Rights for their entire staff. The workshop was conducted by senior staff of the firm from 17th to 19thSeptember 2007. The workshop covered all aspects of IP rights including aspects of licensing rights.